These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 32957745)

  • 1. Multiple myeloma in 2020: state of the art.
    Cerchione C; Martinelli G
    Panminerva Med; 2020 Dec; 62(4):191-192. PubMed ID: 32957745
    [No Abstract]   [Full Text] [Related]  

  • 2. Myeloma research on the move.
    Ludwig H
    Blood Cancer J; 2021 Sep; 11(9):155. PubMed ID: 34535632
    [No Abstract]   [Full Text] [Related]  

  • 3. Cellular immunotherapy in multiple myeloma.
    Vo MC; Lakshmi TJ; Jung SH; Cho D; Park HS; Chu TH; Lee HJ; Kim HJ; Kim SK; Lee JJ
    Korean J Intern Med; 2019 Sep; 34(5):954-965. PubMed ID: 30754964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple Myeloma: The CAR T-cell Therapy Landscape.
    Cancer Discov; 2020 Feb; 10(2):OF6. PubMed ID: 31915196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the safety of autologous stem cell transplant pathway via ambulatory care for patients with multiple myeloma.
    Yip HM; Yong K; De-Silva D; Rabin N
    Hematol Oncol Stem Cell Ther; 2021 Jun; 14(2):160-162. PubMed ID: 32192978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney Transplant in the Era of Modern Therapy for Multiple Myeloma.
    Huskey JL; Heilman RL; Khamash H; Fonseca R
    Transplantation; 2018 Dec; 102(12):1994-2001. PubMed ID: 30211830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serial treatment of relapsed/refractory multiple myeloma with different BCMA-targeting therapies.
    Cohen AD; Garfall AL; Dogan A; Lacey SF; Martin C; Lendvai N; Vogl DT; Spear M; Lesokhin AM
    Blood Adv; 2019 Aug; 3(16):2487-2490. PubMed ID: 31451444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marrow-Infiltrating Lymphocytes Are Effective in Multiple Myeloma.
    Cancer Discov; 2015 Jul; 5(7):689. PubMed ID: 26022609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From the guest editor: the evolving treatment paradigm in multiple myeloma.
    Anderson KC
    Cancer J; 2009; 15(6):456. PubMed ID: 20010163
    [No Abstract]   [Full Text] [Related]  

  • 10. Multiple myeloma. Progress is being made.
    Mayo Clin Health Lett; 2011 Mar; 29(3):4-5. PubMed ID: 21553706
    [No Abstract]   [Full Text] [Related]  

  • 11. CAR T-cell therapy against B-cell maturation antigen in multiple myeloma.
    Cohen AD
    Clin Adv Hematol Oncol; 2018 Dec; 16(12):804-806. PubMed ID: 30843888
    [No Abstract]   [Full Text] [Related]  

  • 12. Adoptive immunotherapy for relapsed multiple myeloma after allogeneic bone marrow transplantation (BMT): evidence for a graft-versus-myeloma effect.
    Bertz H; Burger JA; Kunzmann R; Mertelsmann R; Finke J
    Leukemia; 1997 Feb; 11(2):281-3. PubMed ID: 9009093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunology and immunotherapeutic approaches in multiple myeloma.
    Schlude C; Beckhove P
    Recent Results Cancer Res; 2011; 183():97-109. PubMed ID: 21509682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospects of combining adoptive cell immunotherapy with bortezomib.
    Pellom ST; Singhal A; Shanker A
    Immunotherapy; 2017 Mar; 9(4):305-308. PubMed ID: 28303766
    [No Abstract]   [Full Text] [Related]  

  • 15. Multiple myeloma.
    Chavda SJ; Yong K
    Br J Hosp Med (Lond); 2017 Feb; 78(2):C21-C27. PubMed ID: 28165783
    [No Abstract]   [Full Text] [Related]  

  • 16. Two Rare Cases of Therapy-Related Acute Lymphoblastic Leukemia in Patients With Plasma Cell Myeloma.
    Lee HY; Park CJ; Ahn A; Lee MY; Cho YU; Jang S; Seo EJ; Lee KH; Lee JH
    Ann Lab Med; 2019 Sep; 39(5):496-498. PubMed ID: 31037870
    [No Abstract]   [Full Text] [Related]  

  • 17. SOHO State of the Art Updates and Next Questions: T-Cell-Directed Immune Therapies for Multiple Myeloma: Chimeric Antigen Receptor-Modified T Cells and Bispecific T-Cell-Engaging Agents.
    Madduri D; Dhodapkar MV; Lonial S; Jagannath S; Cho HJ
    Clin Lymphoma Myeloma Leuk; 2019 Sep; 19(9):537-544. PubMed ID: 31427259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiples Myelom - ASCO 2016 - Bestätigung der ASZT und neue Daten zur systemischen Therapie.
    Oncol Res Treat; 2016; 39(11):732-733. PubMed ID: 27855381
    [No Abstract]   [Full Text] [Related]  

  • 19. Infusion of chimeric antigen receptor T cells against dual targets of CD19 and B-cell maturation antigen for the treatment of refractory multiple myeloma.
    Tang F; Lu Y; Ge Y; Shang J; Zhu X
    J Int Med Res; 2020 Jan; 48(1):300060519893496. PubMed ID: 31939323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of marrow failure after CARTs for myeloma by the infusion of cryopreserved stem cells.
    Yan L; Shang J; Shi X; Kang H; Liu W; Xu N; Liu Y; Chen G; Kang L; Gong F; Tang F; Yu L; Wu D; Fu C
    Am J Hematol; 2020 Jan; 95(1):E20-E23. PubMed ID: 31637745
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.